Table 1.
Baseline patient characteristics
| Baseline characteristics (n=130) # | Result |
|---|---|
| Median age in years (IQR) | 9.8 (5.9, 13.8) |
| Female | 86 (66) |
| Some White ethnicity§, n (%) | 101 (78) |
| Median days after diagnosis at enrolment (IQR) | 24 (15, 24) |
| GC starting dosage, median (IQR) mg/kg/day | |
| Low | 0.09 (0.07, 0.10) |
| Moderate | 0.50 (0.35, 0.70) |
| High | 3.60 (1.60, 8.00) |
| Days in receipt of GC between study visits, median (IQR) % | |
| All patients | 74 (37, 100) |
| Low starting dose group | 5 (0.2, 20) |
| Moderate starting dose group | 66 (20, 96) |
| High starting dose group | 81 (46, 100) |
| Patients in each GC group⌘ | |
| Low | 4 (3) |
| Moderate | 50 (39) |
| High | 76 (59) |
| Diagnosis⌘ | |
| Juvenile idiopathic arthritis (all subtypes) | 49 (38) |
| Systemic arthritis | 24 (18) |
| Polyarthritis, rheumatoid factor negative | 8 (6) |
| Polyarthritis, rheumatoid factor positive | 5 (4) |
| Enthesitis related arthritis | 3 (2) |
| Oligoarticular arthritis | 3 (2) |
| Psoriatic arthritis | 2 (2) |
| Unclassified | 4 (3) |
| Juvenile dermatomyositis | 30 (23) |
| Systemic lupus erythematyosus | 20 (15) |
| Localized scleroderma | 10 (8) |
| Systemic scleroderma | 1 (1) |
| Overlap syndromes (including mixed connective tissue disease) | 5 (4) |
| Chronic systemic vasculitis* | 14 (11) |
| CNS vasculitis | 1 (1) |
#
Values are the number (percentage) unless otherwise indicated. IQR = interquartile range; GC = glucocorticoid; CNS = central nervous system.
§
Includes all patients with any amount of white ethnicity.
⌘
Total of 101% due to rounding.
*
Includes Takayasu’s arteritis, granulomatosis with polyangiitis (Wegener’s), microscopic polyangiitis, perinuclear antineutrophil cytoplasmic antibody (pANCA)-positive renal limited vasculitis, and pANCA-positive vasculitis with Goodpasture’s syndrome.